ABSTRACT
Background: Mother is the pillar of the family and maternaldeaths during pregnancy and delivery are great loss to baby,family, society and country too. Maternal mortality is anindicator of the quality of obstetric care in a community directlyreflecting the utilization of health care services available.Aims and Objectives: The aim is to study the incidence ofmaternal mortality, to assess the epidemiological aspects,causes of maternal mortality and avoidable factors that canprevent maternal deaths.Method: A retrospective study was done at Rangpur MedicalCollege Hospital from January 2018 to December 2018.Results: A total of 49 deaths were analyzed. Maximummaternal deaths were reported in the age group of 20-30 yearswhich was 67.34%. More deaths were among multiparouswomen which was 24.48% as compared to primipara 6.12%.Deaths among multigravida was 38.77% which was also morethan primigravida 30.61%. Majority of women 91.83% werehousewives and 8.16% women were service holder. Most ofthem were unbooked cases 63.26%. Among them 59.18%belong to rural area 46.8% belongs to urbane area. Mostmaternal deaths were due to obstetric causes like postpartumhaemorrhage 44.89%, Eclampsia 32.65%, antepartumhaemorrhage 6.12%, ruptured uterus 2.04%, puerperal sepsis2.04%, severe pre eclampsia 2.04%. Associated co-morbidfactors were AKI with DIC due to IUFD 2.04%, AKI with hepaticencephalopathy 2.04%, Anaemic heart failure with AKI 2.04%,Encephalitis 2.04%, IFUD with 53% mixed type flame burn2.04%.Conclusion: Maternal mortality even today is a preventabletragedy by giving proper antenatal care, early referral, quickefficient transport facilities, continued skill based training, upgradation of hospitals, setting up a system of audit andmonitoring of health services can reduce maternal mortality.
ABSTRACT
A prospective study was carried out during 1st September 1995 to 31 st August in private patients of Sir Ganga Ram Hospital, Lahore. The purpose was to study the safety and efficacy of decapeptyl in the treatment of endometriosis. Six women with proven endometriosis were treated with a delayed release preparation of the super active agonist D. Trp-6-LH-RH in biodegradable microcapsules, administered intra-muscularly at intervals of 30 days for a period of 6 months. All patients showed clinical improvement and reduction in stage and score of endometriosis. Hot flushes and dyspareunia were the main side effects. Resumption of menses occurred in all patients after the last injection. Results demonstrate that a long lasting, reversible hypogonadism can be induced in cyclic women by intramuscular injections of D. Trp-6-LH-RH microcapsules at monthly intervals. This simple and conventient treatment should be useful in treating endomentriosis